Top brokers name 3 ASX shares to sell today

Top brokers have given Australian Pharmaceutical Industries Ltd (ASX:API) and two other shares sell ratings this week. Here's why…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

On Wednesday I looked at a few shares that have recently found favour with brokers and been given buy ratings.

Unfortunately, not all shares on the market are in favour with brokers right now. Three which have been given sell ratings are listed below. Here's why brokers think you should avoid them:

Australian Pharmaceutical Industries Ltd (ASX: API)

According to a note out of Credit Suisse, it has downgraded this pharmacy chain operator and supplier's shares to an underperform rating from neutral with a lowered price target of $1.55. The broker believes that the company's shares could come under pressure next month when its reports its latest results. Credit Suisse appears to think that investors have become too focused on its Clearskincare acquisition and lost focus on the challenging operating environment its core business is facing. I agree with Credit Suisse on Australian Pharmaceutical Industries and think investors ought to stay clear of its shares until they have seen its results.

Independence Group NL (ASX: IGO)

A note out of the Macquarie equities desk reveals that its analysts have downgraded the miner's shares to an underperform rating from neutral and cut the price target on them to $4.20. According to the note, the broker has made the move after adjusting its nickel price forecasts. This has led to a significant cut to its earnings forecasts for Independence Group this year. I'm sitting on the fence with independence Group and would class it as a hold at these levels.

Nufarm Limited (ASX: NUF)

Analysts at Deutsche Bank have retained their sell rating and cut the price target on this crop protection company's shares to $6.10 following the release of a weaker than expected full year result on Wednesday. According to the note, the broker appears concerned by numerous risks that Nufarm faces such as drought, higher input costs, and U.S. tariffs. I agree with Deutsche and would avoid Nufarm's shares after that result. I don't believe its shares are trading at a level that offers a sufficient risk/reward.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

A happy young couple lie on a wooden deck using a skateboard for a pillow.
Share Gainers

These were the best-performing ASX 200 shares in March

These shares made their shareholders smile in March thanks to some very big gains.

Read more »

Businessman using a digital tablet with a graphical chart, symbolising the stock market.
Opinions

2 ASX shares I have been buying in 2024!

I’m a believer in the long-term outlook of these stocks.

Read more »

Stock market chart in green with a rising arrow symbolising a rising share price.
Share Gainers

Here are the top 10 ASX 200 shares today

It was a massive day for the ASX 200, with a new all-time high recorded.

Read more »

A man sits thoughtfully on the couch with a laptop on his lap.
Technology Shares

This ASX tech stock rocketed 60% in March! Can it keep on delivering?

After soaring in March, the ASX tech stock is now up 169% since this time last year.

Read more »

Broker Notes

Brokers name 3 ASX shares to buy now

Here's why brokers are feeling bullish about these three shares this week.

Read more »

A young man clasps his hand to his head with his eyes closed and a pained expression on his face as he clasps a laptop computer in front of him, seemingly learning of bad news or a poor investment.
Share Fallers

Why Burgundy Diamond Mines, Clarity Pharmaceuticals, EML, and Zip are sinking today

These ASX shares are ending the week in the red. But why?

Read more »

A young women pumps her fists in excitement after seeing some good news on her laptop.
Share Gainers

Why Mesoblast, Newmont, Pilbara Minerals, and Platinum shares are jumping

These ASX shares are ending the week strongly. But why?

Read more »

a young boy dressed up in a business suit and tie has a cute grin and holds two fingers up.
Opinions

2 of my top ASX 200 shares to consider buying before April

I would happily exchange dollars for these two shares right now.

Read more »